| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/06/2013 | EP2552958A2 Monoclonal antibody directed against the p17 protein of hiv, capable of neutralising the binding of p17 to the p17 receptor (p17r) |
| 02/06/2013 | EP2552957A1 Antibodies with enhanced or suppressed effector function |
| 02/06/2013 | EP2552956A1 Anti-kit antibodies and uses thereof |
| 02/06/2013 | EP2552955A2 Antibodies with modified affinity to fcrn that promote antigen clearance |
| 02/06/2013 | EP2552947A2 Vista regulatory t cell mediator protein, vista binding agents and use thereof |
| 02/06/2013 | EP2552944A1 Compositions and methods for the removal of biofilms |
| 02/06/2013 | EP2552488A1 Fusion protein and its uses |
| 02/06/2013 | EP2552485A1 Full-length immunoglobulins of the igg isotvpe capable of recognizing a heterosubtvpe neutralizing epitope on the hemagglutinin stem region and their use as anti-influenza medicament |
| 02/06/2013 | EP2552483A1 Antibody-based depletion of antigen-presenting cells and dendritic cells |
| 02/06/2013 | EP2552481A1 Bispecific antibodies |
| 02/06/2013 | CN102918154A Gene Dro1 controlling deep-rooted characteristics of plant and utilization of same |
| 02/06/2013 | CN102918063A Anti-cd40 antibodies |
| 02/06/2013 | CN102918062A Therapeutic methods using anti-CD200 antibodies |
| 02/06/2013 | CN102918061A Antibodies against human CSF-1R and uses thereof |
| 02/06/2013 | CN102918060A Antibodies against human CSF-1R and uses thereof |
| 02/06/2013 | CN102918059A Anti-CD27 antibody |
| 02/06/2013 | CN102918058A Targeted binding agents against B7-H1 |
| 02/06/2013 | CN102918057A Antigen-binding molecules that promote antigen clearance |
| 02/06/2013 | CN102918053A Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same |
| 02/06/2013 | CN102917732A Immunoglobulin preparation and storage system for an immunoglobulin preparation |
| 02/06/2013 | CN102917729A Immunogenic proteins and compositions |
| 02/06/2013 | CN102911987A Cells of which genome is modified |
| 02/06/2013 | CN102911919A Bar/PAT protein monoclonal antibody, method for preparing same and application of bar/PAT protein monoclonal antibody |
| 02/06/2013 | CN102911271A Anti-CTNNB1 monoclonal antibody 12H7 and application thereof |
| 02/06/2013 | CN102911270A Preparation and purification method of antibody for inhibiting chronic rejection of transplanted organ |
| 02/06/2013 | CN102911269A Preparation method of sugarcane smut pathogen polyclonal antibody |
| 02/06/2013 | CN102911268A Process for concentration of antibodies and therapeutic products thereof |
| 02/06/2013 | CN102250214B Polypeptide for resisting rheumatoid arthritis and application of polypeptide in pharmacy |
| 02/06/2013 | CN101497665B Human fiber plasminogen Kringle5 polyclonal antibody, and preparation and use thereof |
| 02/06/2013 | CN101440131B Antibody variable region of a monoclonal antibody against human tumor necrosis factor alpha and a gene encoding the same |
| 02/06/2013 | CN101155832B 抗体的改良方法 Improved methods of antibody |
| 02/05/2013 | US8367888 Mouse λ light chain locus |
| 02/05/2013 | US8367808 Methods, devices, kits and compositions for detecting whipworm |
| 02/05/2013 | US8367807 Compositions and methods for diagnosis, prognosis and management of malaria |
| 02/05/2013 | US8367806 Protein disulfide isomerase assay method for the in vitro diagnosis of colorectal cancer |
| 02/05/2013 | US8367805 Fc variants with altered binding to FcRn |
| 02/05/2013 | US8367801 Proteinaceous compounds |
| 02/05/2013 | US8367607 Oxyntomodulin peptide analogue |
| 02/05/2013 | US8367407 Cells with altered fucosylation and producing antibodies therefrom |
| 02/05/2013 | US8367405 Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase |
| 02/05/2013 | US8367374 Nucleotide sequences coding golgi transport protein fusion comprised of N-acetylglucosaminyltransferase III or galactosyltransferase activities for use in generating immunoglobulns for use in treatment of cell proliferative and apototic disorders; immunotherapy |
| 02/05/2013 | US8367356 Gelsolin binding agent compositions and uses of same |
| 02/05/2013 | US8367355 Method of quantitative assessment on reproductive effort of black-lip pearl oysters using antibody specific thereto |
| 02/05/2013 | US8367347 Methods for the diagnosis and the prognosis of a brain tumor |
| 02/05/2013 | US8367065 Targeted polymeric prodrugs containing multifunctional linkers |
| 02/05/2013 | US8367063 Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors |
| 02/05/2013 | US8367061 Anti-idiotype monoclonal antibodies mimicking the HIV gp120 CD4-binding (CD4bs) |
| 02/05/2013 | US8367052 Methods for promoting protection and regeneration of bone marrow using CXCL9 and anti-CXCL9 antibodies |
| 02/05/2013 | US8367037 Anti-CD74 immunoconjugates and methods of use |
| 02/05/2013 | CA2676188C Pharmaceutical compositions capable of inducing apoptosis in tumour cells, useful for diagnosis and treatment of the b-chronic lymphocytic leukemia |
| 02/05/2013 | CA2651597C Detection of inflammatory disease and composition for prevention or treatment of inflammatory disease |
| 02/05/2013 | CA2504867C Transgenic mammal carrying ganp gene transferred thereinto and utilization thereof |
| 02/05/2013 | CA2503509C Non-competitive immunoassay for small analytes |
| 02/05/2013 | CA2440221C Expression technology for proteins containing a hybrid isotype antibody moiety |
| 02/05/2013 | CA2429636C Group 2 allergen specific ige-fabs and igg molecules and use thereof |
| 02/05/2013 | CA2420867C Methods for enhancing the efficacy of cancer therapy |
| 02/05/2013 | CA2340091C Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
| 02/05/2013 | CA2320359C Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv) |
| 01/31/2013 | WO2013016714A1 Sur-binding proteins against erbb3 |
| 01/31/2013 | WO2013016648A2 Stabilized formulations containing anti-pcsk9 antibodies |
| 01/31/2013 | WO2013016468A2 Compositions and methods for improving potency and breadth or hiv antibodies |
| 01/31/2013 | WO2013016220A1 Il-17 receptor a is required for il-17c biology |
| 01/31/2013 | WO2013015821A1 Antibodies to the b12-transcobalamin receptor |
| 01/31/2013 | WO2013015367A1 Antibody for detecting epithelial ovarian cancer marker and method for diagnosing epithelial ovarian cancer |
| 01/31/2013 | WO2013015363A1 Antibody for detecting epithelial ovarian cancer marker and method for diagnosing epithelial ovarian cancer |
| 01/31/2013 | WO2013014669A1 Lactoferrin fragments and use thereof |
| 01/31/2013 | WO2013014668A1 Variants of humanized immunomodulatory monoclonal antibodies |
| 01/31/2013 | WO2013014405A2 Methods |
| 01/31/2013 | WO2013014269A1 A method to promote growth of a newborn animal |
| 01/31/2013 | WO2013014255A1 Exosome inhibiting agents and uses thereof |
| 01/31/2013 | WO2013014208A2 Antigen binding constructs |
| 01/31/2013 | WO2013014092A1 Inhibitory anti -factor xii/xiia monoclonal antibodies and their uses |
| 01/31/2013 | WO2013013700A1 Multivalent antigen-binding fv molecule |
| 01/31/2013 | WO2013013323A1 Staphlococcus aureus alpha-hemolysin antibodies |
| 01/31/2013 | WO2012162067A3 Cd3-binding molecules capable of binding to human and non-human cd3 |
| 01/31/2013 | WO2012149412A3 Anti-endoglin (cd105) antibodies, immunoconjugates, and uses thereof |
| 01/31/2013 | WO2012122125A3 Compositions and methods targeting force generation in kinesin |
| 01/31/2013 | WO2012112842A3 Compositions and methods for treating poliovirus |
| 01/31/2013 | WO2012006341A8 Anti-ron antibodies |
| 01/31/2013 | US20130031647 Humanized anti cxcr4 antibodies for the treatment of cancer |
| 01/31/2013 | US20130030159 Anti-activin a antibodies and uses thereof |
| 01/31/2013 | US20130030158 Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins |
| 01/31/2013 | US20130030157 Rodent Combinatorial Antibody Libraries |
| 01/31/2013 | US20130030156 Anti-ilt5 antibodies and ilt5-binding antibody fragments |
| 01/31/2013 | US20130030155 Antibodies to the notch1 receptor |
| 01/31/2013 | US20130029902 Cxc chemokine receptor 4 (cxcr4) antagonistic polypeptide |
| 01/31/2013 | US20130029880 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
| 01/31/2013 | US20130029868 Methods and kits for the detection of cancer infiltration of the central nervous system |
| 01/31/2013 | US20130029399 Metal salen complex derivative and process for production thereof |
| 01/31/2013 | US20130029366 Ptp1b inhibitors |
| 01/31/2013 | US20130029360 Dimeric core-shell nanostructure labeled with raman active molecule localized at interparticle junction, use thereof, and method for preparing the same |
| 01/31/2013 | US20130029359 Monoclonal antibodies and diagnostic uses thereof |
| 01/31/2013 | US20130029330 Mutant ldl receptor gene |
| 01/31/2013 | US20130029327 Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof |
| 01/31/2013 | US20130029322 Anti-hpv e7 antibodies |
| 01/31/2013 | US20130028918 Insulin conjugate using an immunoglobulin fragment |
| 01/31/2013 | US20130028917 Pyrrolobenzodiazepines and conjugates thereof |
| 01/31/2013 | US20130028914 Antibodies that Bind Tau Oligomers |
| 01/31/2013 | US20130028913 Antibody that binds to h-1 parvovirus |
| 01/31/2013 | US20130028911 Vascular endothelial cell growth factor antagonists |